Mia's Feed
Medical News & Research

Annual Low-Dose Whole-Body CT Scan Enhances Monitoring of Smoldering Multiple Myeloma

Annual Low-Dose Whole-Body CT Scan Enhances Monitoring of Smoldering Multiple Myeloma

Share this article

2 min read

Recent research has demonstrated that conducting yearly low-dose whole-body computed tomography (WBLDCT) scans significantly improves the management of patients with smoldering multiple myeloma (SMM). The study, published online on March 25 in the Journal of Clinical Medicine, highlights the important role of early detection of disease progression in this patient population.

Led by Dr. Ioannis Ntanasis-Stathopoulos from the General Alexandra Hospital and the National and Kapodistrian University of Athens in Greece, the research involved evaluating 113 patients with SMM who underwent annual WBLDCT assessments. The primary focus was on identifying early signs of bone deterioration and progression to symptomatic multiple myeloma.

The findings revealed that approximately 36.3% of the studied patients progressed to active multiple myeloma over the follow-up period. Notably, nearly 10% of these cases exhibited disease progression solely through the appearance of new bone lesions, emphasizing the crucial role of imaging in early detection.

The authors concluded that incorporating yearly WBLDCT scans into routine care for SMM patients can significantly aid in early detection of disease progression. Due to the strong association between radiologically detected bone lesions and progression risk, these imaging assessments are recommended to refine patient monitoring strategies and optimize management approaches.

This study underscores the importance of regular imaging in the early intervention of smoldering multiple myeloma, potentially leading to improved patient outcomes.

Source: https://medicalxpress.com/news/2025-04-annual-body-dose-ct-aids.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Oncologists Advocate for Age-Inclusive Licensing of Cancer Treatments

Experts call for universal approval of tissue-agnostic cancer drugs across all ages to improve treatment access for children and adults alike.

Rapid Spread of Drug-Resistant Fungus C. auris in European Hospitals

New findings reveal that the drug-resistant fungus Candida auris is rapidly spreading across European hospitals, posing a significant threat to patient safety and infection control efforts. Early detection and coordinated response are crucial to stopping its spread.

Advances in Gene Therapy: New Insights into Genome Ejection Mechanisms of AAV Vectors

New research from the University of Osaka uncovers the molecular mechanisms of genome ejection in AAV vectors, offering promising avenues for improved gene therapy vector design and safety.